|
It is the unqualified policy of the Center for Healthcare Supply Chain Research ('the Center') and all of its operating committees to conduct their operations in strict compliance with the antitrust laws of the United States.
The Center’s antitrust policy prohibits any discussions which constitute or imply an agreement or understanding concerning: 1) prices, discounts, or terms or conditions of sale; 2) profits, or profit margins or cost data; 3) market shares, sales territories or markets; 4) allocation of customers or territories; 5) selection, rejection or termination of customers or suppliers; 6) restricting the territory or markets in which a company may resell products; 7) restricting the customers to whom a company may sell; or 8) any matter which is inconsistent with the proposition that each member company of the Center must exercise its independent business judgment in pricing its services or products, dealing with its customers and suppliers and choosing the markets in which it will compete.
Center membership, Board of Directors and committee meetings shall be conducted pursuant to agendas distributed in advance to attendees; discussions shall be limited to agenda items which have been reviewed by Center legal counsel; there shall be no substantive discussions of Center matters other than at official meetings; and minutes shall be distributed to attendees promptly upon review by Center legal counsel.
|
